EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1

Jingmei Cao, Qing Zhao, Qing Jia, Yiming Li

Cellular and Molecular Biology · 2023

DOI: 10.14715/cmb/2023.69.7.29 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular and Molecular Biology, 2023. Verfasst von Jingmei Cao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zibo Central Hospital, Zibo, Shandong,255000, China. 18953350001@189.cn. Hauptthemen laut MEDLINE: Colitis, Ulcerative, MicroRNAs, RNA, Long Noncoding. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Growing evidence suggested that long non-coding RNA (lncRNA) played a crucial role in the progression of ulcerative colitis (UC). Therefore, the purpose of this study is to understand how the lncRNA CBR3-AS1, which has been found to be up-regulated in UC, contributes to the bio-progression of the disease. To determine the concentration and relationship of the lncRNA CBR3-AS1, miRNA-145-5p, and FN1 in the LPS-induced Caco-2 model cells, qRT-PCR was employed in this study. Starbase was used to predict the target sites of the lncRNA CBR3-AS1 and the miRNA-145-5p, and Targetscan was used to predict the probable linking points of the FN1 and the miRNA-145-5p, which was confirmed by a twofold luciferase reporter test. The vitality of Caco-2 cells was determined using the CCK-8 and FCM tests. Using the ELISA kit, TNF, IFN, IL-6, and IL-17 were identified. The results of the experiment show that in Caco-2 cells treated with 10 ng/mL LPS, LncRNA CBR3-AS1 was up-regulated. Additionally, Caco-2 cells' LPS-induced apoptosis and inflammatory response were inhibited by lncRNA CBR3-AS1 inhibition. Dual-luciferase reporter experiments demonstrated that miRNA-145-5p and lncRNA CBR3-AS1 might connect. Moreover, miRNA-145-5p, which was shown to be poorly expressed in UC, was found to suppress inflammatory and apoptotic responses in Caco-2 cells activated by LPS. It's significant that FN1 was confirmed to be miRNA-145-5p's downstream target. Sh-CBR3-AS1's inhibitory effects were reversed by miRNA-145-5p knockdown, and the effects of the miRNA-145-5p inhibitor were reversed by sh-FN1. In conclusion, LncRNA CBR3-AS1 may offer a unique method for treating UC by suppressing the function of miRNA-145-5p, which is implicated in the development of UC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeMicroRNAsRNA, Long NoncodingHumansCaco-2 CellsLipopolysaccharides

Substanzen

LipopolysaccharidesMicroRNAsMIRN145 microRNA, humanPlncRNA-1, humanRNA, Long Noncoding

Autor:innen und Institutionen

  • Department of Gastroenterology, Zibo Central Hospital, Zibo, Shandong,255000, China. 18953350001@189.cn.
  • Department of Gastroenterology, Zibo Central Hospital, Zibo, Shandong,255000, China. Qingzh0801@163.com.
  • Department of Gastroenterology, Zibo Central Hospital, Zibo, Shandong,255000, China. 690015711@qq.com.
  • Department of Traditional Chinese Medicine, Zibo Central Hospital, Zibo, Shandong, 255000, China. 13969390782@163.com.

Zitieren

APA

Cao, J., Zhao, Q., Jia, Q., & Li, Y. (2023). LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1. Cellular and Molecular Biology. https://doi.org/10.14715/cmb/2023.69.7.29

Vancouver

Cao J, Zhao Q, Jia Q, Li Y. LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1. Cellular and Molecular Biology. 2023. doi:10.14715/cmb/2023.69.7.29

BibTeX
@article{Cao2023,
  author = {Cao, Jingmei and Zhao, Qing and Jia, Qing and Li, Yiming},
  title = {LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1},
  journal = {Cellular and Molecular Biology},
  year = {2023},
  doi = {10.14715/cmb/2023.69.7.29}
}
Kostenlos starten →